In Kaplan‒Meier survival analysis, higher levels of c‐Myc (p = 1.0 × 10−3), EPRS (p = 1.3 × 10−3), LARS (p = 3.0 × 10−6), GOT1 (p = 9.9 × 10−3) or MDH1 (p = 4.8 × 10−4), and lower levels of LMNA (p = 6.1 × 10−5) were linked to worse outcome of 498 NB cases (GSE62564; Figure 8D). Here, LARS1 is linked to neuroblastoma.